baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

BVT Knock-Out PGR/ DE000VD1LL48 /

13/05/2024 13:45:14	Chg.-0.180	Bid15:55:47	Ask15:55:47	Underlying	Strike price	Expiration date	Option type
1.780EUR	-9.18%	2.060 Bid Size: 16,000	2.080 Ask Size: 16,000	Progressive Corporat...	235.65 -	31/12/2078	Put

GlobeNewswire 15:33 Cytokinetics Announces Primary Results From SEQUOIA-HCM Presented in Late Breaking Clinical Trial Se...

GlobeNewswire 15:33 Cytokinetics Announces Additional Results From SEQUOIA-HCM Presented in Late Breaking Clinical Trial...

GlobeNewswire 15:00 Galaxy Gaming Reports Q1 2024 Financial Results

GlobeNewswire 14:35 DeFi Technologies Inc. Featured in Syndicated Broadcast Covering Subsidiary’s AUM of C$748M, a 47.2%...

GlobeNewswire 14:15 Benitec Biopharma Releases Third Quarter 2024 Financial Results and Provides Operational Update

GlobeNewswire 14:00 GRI Bio Reports First Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire 14:00 Avalyn Announces Multiple Presentations on its Lead Program, AP01, for Pulmonary Fibrosis and its Ap...

GlobeNewswire 13:30 BridgeBio Pharma Presents Additional Data and Analyses from its Phase 3 ATTRibute-CM Study in Transt...

GlobeNewswire 13:00 Tiziana Life Sciences Files for Orphan Drug Designation for Intranasal Foralumab

GlobeNewswire 13:00 Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 20...

GlobeNewswire 12:00 Fulcrum Therapeutics Enters into a Collaboration and License Agreement with Sanofi for the Developme...

GlobeNewswire 08:30 Inventiva announces the publication in Nature Communications of additional results from NATIVE Phase...

GlobeNewswire 09/05 Travere Therapeutics to Present at National Kidney Foundation Spring Clinical Meetings and the 61st ...

GlobeNewswire 09/05 Freeline Presents Positive New Data from Phase 1/2 Trial of FLT201, Its Novel Gene Therapy Candidate...

GlobeNewswire 08/05 Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Plan...

GlobeNewswire 07/05 MediciNova Receives Issue Notification for New Patent Covering Extended-Release Formulations of MN-1...

GlobeNewswire 06/05 Belite Bio Presents Additional Analysis from Phase 2 Study of Tinlarebant in Stargardt Disease at th...

GlobeNewswire 04/05 The National Fire Sprinkler Association's Class of 2024: Honoring Fire Sprinkler Industry Greats

GlobeNewswire 02/05 PyroGenesis Announces 28-Day Lab Strength Tests Achieve Up to 99.56% Above Compressive Strength Targ...

GlobeNewswire 01/05 Belite Bio Announces Presentation at the Association for Research in Vision and Ophthalmology 2024 A...

GlobeNewswire 01/05 Aileron Therapeutics Announces Positive Data from Cohort 1 of the Phase 1b Clinical Trial of LTI-03 ...

GlobeNewswire 01/05 Opthea Announces Upcoming Presentations at the Retina World Congress 2024

GlobeNewswire 01/05 Atsena Therapeutics Announces Positive Clinical Data from the First Cohort of Phase I/II Trial Evalu...

GlobeNewswire 01/05 TG Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results

GlobeNewswire 30/04 Progressive Announces Investor Relations Call

BVT Knock-Out PGR/ DE000VD1LL48 /

If you wish to receive reply to your feedback, please provide your email address.